Tissue | 3H-FLT uptake level ((%ID/g)×kg) | ||
---|---|---|---|
Control | Gefitinib 100 | Gefitinib 200 | |
n = 8 | n = 7 | n = 7 | |
Blood | 0.088 ± 0.009 | 0.080 ± 0.017 | 0.091 ± 0.012 |
Tumor | 0.589 ± 0.112 | 0.393 ± 0.093* | 0.360 ± 0.059* |
Muscle | 0.093 ± 0.008 | 0.088 ± 0.013 | 0.094 ± 0.008 |
Heart | 0.094 ± 0.012 | 0.085 ± 0.012 | 0.092 ± 0.008 |
Brown fat | 0.082 ± 0.010 | 0.076 ± 0.006 | 0.083 ± 0.009 |
Lung | 0.091 ± 0.012 | 0.085 ± 0.011 | 0.094 ± 0.007 |
Brain | 0.016 ± 0.001 | 0.015 ± 0.001 | 0.015 ± 0.001 |
Spleen | 0.115 ± 0.026 | 0.113 ± 0.025 | 0.122 ± 0.033 |
Liver | 0.103 ± 0.014 | 0.100 ± 0.017 | 0.105 ± 0.012 |
Kidney | 0.147 ± 0.016 | 0.132 ± 0.020 | 0.138 ± 0.014 |
Skin | 0.089 ± 0.019 | 0.094 ± 0.009 | 0.092 ± 0.010 |
Tumor/muscle ratio | 6.3 ± 1.3 | 4.6 ± 1.4* | 3.8 ± 0.6* |